(GEVO) Gevo - Ratings and Ratios
Aviation Fuel, Renewable Diesel, Alcohol Fuels, Natural Gas
GEVO EPS (Earnings per Share)
GEVO Revenue
Description: GEVO Gevo October 27, 2025
Gevo, Inc. (NASDAQ:GEVO) positions itself as a carbon-abatement firm operating through three business lines-Gevo, GevoFuels, and GevoRNG-producing sustainable aviation fuel (SAF), renewable motor fuels, specialty chemicals, and renewable natural gas (RNG) via its Alcohol-to-Jet (ATJ) and anaerobic-digestion platforms. The company also runs the Verity digital platform to track and verify supply-chain metrics, and it rebranded from Methanotech in 2006 after its 2005 incorporation in Englewood, Colorado.
Recent disclosures (Q2 2024) show Gevo operating ~30 million gallons of SAF-ready isobutanol capacity, a 15 % YoY increase in RNG production (≈1.2 MMcf), and a cash balance of $120 million, enough to fund its next two ATJ projects without additional equity raises. The firm recently secured a offtake agreement with United Airlines for 5 million gallons of SAF per year, which, if executed, would lift its SAF revenue runway through 2027.
Key macro drivers for Gevo include: (1) the ICAO CORSIA program and U.S. SAF tax credits, which together could lift SAF demand by an estimated 12 % CAGR through 2030; (2) volatile natural-gas prices that affect RNG economics-higher gas prices improve RNG margins but increase feedstock costs for isobutanol; and (3) the broader renewable-fuels credit market, where the Renewable Fuel Standard (RFS) credit price currently trades around $2.30 per gallon, providing a material subsidy to Gevo’s fuel portfolio.
For a data-rich, model-ready view of how these variables translate into valuation upside, you may find ValueRay’s granular analyst dashboards worth a deeper look.
GEVO Stock Overview
| Market Cap in USD | 530m |
| Sub-Industry | Oil & Gas Refining & Marketing |
| IPO / Inception | 2011-02-09 |
GEVO Stock Ratings
| Growth Rating | -0.49% |
| Fundamental | 36.3% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 21.4% |
| Analyst Rating | 3.33 of 5 |
GEVO Dividends
Currently no dividends paidGEVO Growth Ratios
| Growth Correlation 3m | 81.2% |
| Growth Correlation 12m | 20.6% |
| Growth Correlation 5y | -70.9% |
| CAGR 5y | -3.17% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.04 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.06 |
| Sharpe Ratio 12m | -1.14 |
| Alpha | -30.50 |
| Beta | 1.437 |
| Volatility | 89.94% |
| Current Volume | 4942.7k |
| Average Volume 20d | 4942.7k |
| Stop Loss | 2 (-8.7%) |
| Signal | -0.63 |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-58.3m TTM) > 0 and > 6% of Revenue (6% = 4.81m TTM) |
| FCFTA -0.13 (>2.0%) and ΔFCFTA 3.73pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 121.2% (prev 1283 %; Δ -1162 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.08 (>3.0%) and CFO -56.4m > Net Income -58.3m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.33 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (236.8m) change vs 12m ago -0.91% (target <= -2.0% for YES) |
| Gross Margin 44.25% (prev 35.85%; Δ 8.40pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 12.15% (prev 2.94%; Δ 9.21pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -4.86 (EBITDA TTM -25.5m / Interest Expense TTM 9.86m) >= 6 (WARN >= 3) |
Altman Z'' -7.25
| (A) 0.14 = (Total Current Assets 170.4m - Total Current Liabilities 73.2m) / Total Assets 702.1m |
| (B) -1.17 = Retained Earnings (Balance) -819.9m / Total Assets 702.1m |
| warn (B) unusual magnitude: -1.17 — check mapping/units |
| (C) -0.07 = EBIT TTM -47.9m / Avg Total Assets 660.0m |
| (D) -3.68 = Book Value of Equity -817.5m / Total Liabilities 222.3m |
| Total Rating: -7.25 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 36.26
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield -14.28% = -5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.36 = 2.44 |
| 5. Debt/Ebitda -4.47 = -2.50 |
| 6. ROIC - WACC (= -15.33)% = -12.50 |
| 7. RoE -12.04% = -2.01 |
| 8. Rev. Trend 81.50% = 6.11 |
| 9. EPS Trend 54.38% = 2.72 |
What is the price of GEVO shares?
Over the past week, the price has changed by -3.52%, over one month by -3.52%, over three months by +75.20% and over the past year by +37.74%.
Is Gevo a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GEVO is around 2.19 USD . This means that GEVO is currently overvalued and has a potential downside of 0%.
Is GEVO a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the GEVO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.9 | 170.3% |
| Analysts Target Price | 5.9 | 170.3% |
| ValueRay Target Price | 2.5 | 12.3% |
GEVO Fundamental Data Overview November 10, 2025
P/S = 6.6049
P/B = 1.0355
P/EG = -0.01
Beta = 1.437
Revenue TTM = 80.2m USD
EBIT TTM = -47.9m USD
EBITDA TTM = -25.5m USD
Long Term Debt = 139.6m USD (from longTermDebt, last quarter)
Short Term Debt = 29.8m USD (from shortTermDebt, last quarter)
Debt = 171.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 114.1m USD (from netDebt column, last quarter)
Enterprise Value = 643.7m USD (529.6m + Debt 171.3m - CCE 57.3m)
Interest Coverage Ratio = -4.86 (Ebit TTM -47.9m / Interest Expense TTM 9.86m)
FCF Yield = -14.28% (FCF TTM -91.9m / Enterprise Value 643.7m)
FCF Margin = -114.6% (FCF TTM -91.9m / Revenue TTM 80.2m)
Net Margin = -72.76% (Net Income TTM -58.3m / Revenue TTM 80.2m)
Gross Margin = 44.25% ((Revenue TTM 80.2m - Cost of Revenue TTM 44.7m) / Revenue TTM)
Gross Margin QoQ = 60.23% (prev 26.33%)
Tobins Q-Ratio = 0.92 (Enterprise Value 643.7m / Total Assets 702.1m)
Interest Expense / Debt = 2.54% (Interest Expense 4.34m / Debt 171.3m)
Taxrate = 21.0% (US default 21%)
NOPAT = -37.9m (EBIT -47.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.33 (Total Current Assets 170.4m / Total Current Liabilities 73.2m)
Debt / Equity = 0.36 (Debt 171.3m / totalStockholderEquity, last quarter 474.1m)
Debt / EBITDA = -4.47 (negative EBITDA) (Net Debt 114.1m / EBITDA -25.5m)
Debt / FCF = -1.24 (negative FCF - burning cash) (Net Debt 114.1m / FCF TTM -91.9m)
Total Stockholder Equity = 484.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.31% (Net Income -58.3m / Total Assets 702.1m)
RoE = -12.04% (Net Income TTM -58.3m / Total Stockholder Equity 484.5m)
RoCE = -7.68% (EBIT -47.9m / Capital Employed (Equity 484.5m + L.T.Debt 139.6m))
RoIC = -6.29% (negative operating profit) (NOPAT -37.9m / Invested Capital 601.7m)
WACC = 9.04% (E(529.6m)/V(700.9m) * Re(11.31%) + D(171.3m)/V(700.9m) * Rd(2.54%) * (1-Tc(0.21)))
Discount Rate = 11.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.76%
Fair Price DCF = unknown (Cash Flow -91.9m)
EPS Correlation: 54.38 | EPS CAGR: 166.1% | SUE: 1.14 | # QB: 3
Revenue Correlation: 81.50 | Revenue CAGR: 503.9% | SUE: -0.15 | # QB: 0
Additional Sources for GEVO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle